Found 14 results
Author [ Title(Desc)] Type Year
Filters: Author is Zhi, X  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
E
P. M. Dodson, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., PKC-DRS, R. C. Milton for, and Groups, P. K. C. - D. R. S. Study, Effect of Ruboxistaurin on diabetic macular edema and visual loss: Integrated analysis of the PKC-DRS and PKC-DRS2, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., Effect of Ruboxistaurin on Diabetic Macular Edema and Visual Loss: Integrated Analysis of the PKC-DRS and PKC-DRS2, in American Diabetes Association 66th Scientific Sessions, Washington, DC, 2006.
R. P. Danis, Sheetz, M. J., Aiello, L. P., Davis, M. D., Milton, R. C., Girach, A., Zhi, X., and Group, V. L. for the, Effect of Ruboxistaurin on reversibility of vision loss in nonproliferative diabetic retinopathy patients, 2006.
M. Davis, Sheetz, M., Aiello, L., Milton, R., Danis, R., Zhi, X., Girach, A., Jimenez, M., Vignati, L., and Group, P. K. C. - D. R. S. Study, Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-Standing Diabetic Macular Edema, Invest Ophthalmol Vis Sci, vol. 50, pp. 1-4, 2009.
L. Aiello, Davis, M., Girach, A., Kles, K., Milton, R., Sheetz, M., Vignati, L., and Zhi, X., Effect of Ruboxistaurin on Visual Loss in Patients With Diabetic Retinopathy, Ophthalmology, vol. 113, no. 12, pp. 2221-2230, 2006.
L. P. Aiello, Vignati, L., ,, Zhi, X., Davis, M. D., Milton, R. C., and Girach, A., Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Vision Loss in Patients with Diabetic Retinopathy: The PKC-DRS2 Study Results, in European Association for the Study of Diabetes - Eye Complications, Aarhus, Denmark, 2006.
R. P. Danis, Girach, A., Aiello, L. P., Davis, M. D., Milton, R. C., Sheetz, M. J., Lin, T. E., Zhi, X., and Group, V. L. for the, The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema, in 24th Annual American society of Retinal Specialists and the 6th Annual European Vitreoretinal Society Meeting, Cannes, France, 2006.
L. Vignati, Sheetz, M. J., Girach, A., Zhi, X., Davis, M. D., and Milton, R. C., Effect of the Oral Protein Kinase C b Inhibitor, Ruboxistaurin, on Visual Acuity in the PKC-DRS2 Study, 2006.
A. Girach, Aiello, L. P., Davis, M. D., Milton, R. C., Sheetz, M. J., Zhi, X., and Group, V. L. for the, Effect of the oral protein Kinase C b Inhibitor, Ruboxistaurin, on visual acuity in the PKC-DRS2 study, 2006.
A. Brucker, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Group, R. C. Milton for, Effect of the orally administered PKC b Inhibitor, Ruboxistaurin, on sustained moderate visual loss in the PKC-DRS2 Study, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R., Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Sustained Moderate Visual Loss in the PKC-DRS2 Study, in 29th Annual Meeting of the Macula Society, San Diego, CA, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results, in American Academy of Ophthalmology, Chicago, IL, 2005.